4.6 Review

Nanomedicine: A Diagnostic and Therapeutic Approach to COVID-19

Related references

Note: Only part of the references are listed.
Review Immunology

A systematic review of asymptomatic infections with COVID-19

Zhiru Gao et al.

Summary: Since the outbreak of COVID-19 at the end of December 2019, it has caused significant harm and challenges to over 200 countries and regions worldwide. Many patients with COVID-19 are asymptomatic or have only mild symptoms, yet they can still spread the virus, making screening for asymptomatic infections difficult and complicating national prevention and control efforts.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Review Immunology

Review Article Genotype and phenotype of COVID-19: Their roles in pathogenesis

Leila Mousavizadeh et al.

Summary: COVID-19 is a novel coronavirus belonging to the Betacoronavirus genus, with similarities and differences in genomic structure compared to other human Betacoronaviruses. It contains at least six open reading frames and important structural proteins are encoded near the one-third of the genome.

JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2021)

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Review Immunology

COVID-19 vaccine: where are we now and where should we go?

Saman Soleimanpour et al.

Summary: The SARS-CoV-2 has caused a global pandemic with the potentially fatal disease, COVID-19, leading to the urgent need for effective vaccines and drugs. Research on COVID-19 vaccine candidates is ongoing, with challenges including finding virulence ability of the virus, suitable experimental models, immune-response study, and designing clinical trials.

EXPERT REVIEW OF VACCINES (2021)

Review Nanoscience & Nanotechnology

Application of Nanotechnology in the COVID-19 Pandemic

Dongki Yang

Summary: COVID-19, caused by SARS-CoV-2, has been a global issue for nearly a year. Development of suitable vaccines and therapeutics, along with the use of intranasal drug delivery and nanotechnology, are promising approaches to combat the pandemic.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)

Article Medicine, General & Internal

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Robert L. Gottlieb et al.

Summary: The study showed that treatment with bamlanivimab and etesevimab was significantly associated with a reduction in SARS-CoV-2 viral load at day 11 in nonhospitalized patients with mild to moderate COVID-19, compared to placebo. However, bamlanivimab monotherapy did not show a significant reduction in viral load. Ongoing clinical trials will focus on assessing the clinical benefits of antispike neutralizing antibodies in COVID-19 patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Medicine, Research & Experimental

Recent endemic coronavirus infection is associated with less-severe COVID-19

Manish Sagar et al.

Summary: The study suggests that individuals with prior endemic coronavirus infections were tested more frequently for respiratory infections, but had similar rates of acquiring SARS-CoV-2. Additionally, patients with previous endemic coronavirus infections experienced less severe cases of COVID-19.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Biochemistry & Molecular Biology

Structural insights into SARS-CoV-2 proteins

Rimanshee Arya et al.

Summary: The unprecedented scale of the ongoing COVID-19 pandemic has led to an intensive global scientific effort to understand various aspects of the disease in a short period. More than three hundred experimental structures of SARS-CoV-2 proteins have been determined recently, revealing the intricate workings of the viral machinery and their potential as drug targets.

JOURNAL OF MOLECULAR BIOLOGY (2021)

Article Medicine, General & Internal

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

D. M. Weinreich et al.

Summary: Recent data indicate that complications and death from Covid-19 may be related to high viral loads. In this trial involving nonhospitalized patients, a cocktail of two neutralizing monoclonal antibodies (REGN-COV2) reduced viral load, with a greater effect in patients with no immune response or high viral load at baseline. Safety outcomes were similar between REGN-COV2 dose groups and the placebo group.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19

Summary: In a platform trial involving patients hospitalized with Covid-19, among 314 patients who were also being treated with remdesivir, those who received the monoclonal antibody LY-CoV555 did not have better pulmonary function at day 5 than those who received placebo. The trial was stopped for futility.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Immunological characteristics govern the transition of COVID-19 to endemicity

Jennie S. Lavine et al.

Summary: The study suggests that infection-blocking immunity to SARS-CoV-2 wanes rapidly while disease-reducing immunity is long-lived. The model predicts that once reaching endemic phase, SARS-CoV-2 may become no more virulent than the common cold. However, a different outcome is predicted for an emergent coronavirus causing severe disease in children.

SCIENCE (2021)

Review Anatomy & Morphology

Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review

Subodh Kumar et al.

Summary: This study provides a detailed summary and evaluation of the most suitable cell lines for SARS-CoV-2 in vitro models, including cell culture-based studies and vaccine production, identifying the most widely used cell lines.

TISSUE & CELL (2021)

Editorial Material Medicine, General & Internal

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 >= 7 days after the 2nd dose

Zain Chagla

ANNALS OF INTERNAL MEDICINE (2021)

Article Infectious Diseases

Erratum for Euro Surveill. 2020;25(3)

Eurosurveillance (2021)

Article Medicine, General & Internal

The Johnson & Johnson Vaccine for COVID-19

Edward H. Livingston et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Biotechnology & Applied Microbiology

Allergic Reactions and Anaphylaxis to LNP-Based COVID-19 Vaccines

S. Moein Moghimi

MOLECULAR THERAPY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 spike D614G change enhances replication and transmission

Bin Zhou et al.

Summary: Research has shown that the D614G substitution in the spike protein of SARS-CoV-2 leads to increased binding and replication potential in humans, as well as significantly higher replication and transmissibility in different animal models, providing an explanation for the global prevalence of this variant in the COVID-19 pandemic.

NATURE (2021)

Letter Medicine, General & Internal

Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Chemistry, Multidisciplinary

Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives

Zimei Wu et al.

Summary: The COVID-19 pandemic has forced scientists and clinicians to race for solutions to save lives and control spread, with mRNA-based vaccines emerging as front-runners due to their safety and efficiency. Innovative delivery technologies, aided by nanotechnology, are needed to overcome barriers for successful vaccine delivery and development.

PHARMACEUTICAL RESEARCH (2021)

Article Oncology

Pro- and Antitumorigenic Capacity of Immunoproteasomes in Shaping the Tumor Microenvironment

Hanna Leister et al.

Summary: The immunoproteasome has opposing roles in the tumor microenvironment, promoting colitis-associated carcinogenesis while exhibiting antitumorigenic activity in melanoma. This suggests that immunoproteasomes may have context-dependent pro- or antitumoral properties.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Biology

Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination

Ruian Ke et al.

Summary: The rapid spread of SARS-CoV-2 from a regional outbreak to a global pandemic necessitated high levels of intervention efforts to mitigate or contain the exponential epidemic growth. The early epidemic grew at exponential rates between 0.18 and 0.29/day, emphasizing the importance of effective control measures.

JOURNAL OF THEORETICAL BIOLOGY (2021)

Review Nanoscience & Nanotechnology

Nanotechnology approaches for global infectious diseases

Ameya R. Kirtane et al.

Summary: Infectious diseases pose a significant burden on global health, particularly in the treatment of diseases like malaria, tuberculosis, and HIV. Nanotechnology shows promise in improving treatment outcomes by enhancing drug targeting and patient adherence.

NATURE NANOTECHNOLOGY (2021)

Letter Medicine, General & Internal

New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications

Salim S. Abdool Karim et al.

Summary: The emergence of SARS-CoV-2 variants, including B.1.1.7 (VOC-202012/01), 501Y.V2 (B.1.351), and P.1 (B.1.1.28.1), has raised concerns about worsening Covid-19 and potential escape from vaccine-induced immunity.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Letter Multidisciplinary Sciences

Appropriate names for COVID-19 variants

Salim S. Abdool Karim et al.

SCIENCE (2021)

Article Multidisciplinary Sciences

Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Hany M. Dabbous et al.

Summary: The study demonstrated that favipiravir is a potential treatment for COVID-19 with efficacy and safety in mild and moderate cases, showing better outcomes in viral infection than hydroxychloroquine in certain aspects.

SCIENTIFIC REPORTS (2021)

Review Chemistry, Multidisciplinary

COVID-19 Pandemic: What about the Safety of Anti-Coronavirus Nanoparticles?

Dina A. Mosselhy et al.

Summary: This manuscript discusses recent findings on SARS-CoV-2, including new factors and pathways for cell entry and induction of neurological symptoms, as well as new virus variants. The authors emphasize the human-animal interfaces of the virus and containment strategies using nanoparticle vaccines. Additionally, toxicity issues of anti-viral nanoparticles and the need for more studies on their safety and public perception are highlighted.

NANOMATERIALS (2021)

Review Materials Science, Multidisciplinary

Nanomedicine for COVID-19: the role of nanotechnology in the treatment and diagnosis of COVID-19

Farzan Vahedifard et al.

Summary: The outbreak of the novel coronavirus has spurred global research into effective drugs and vaccines, with nanomedicine emerging as a promising new therapy due to its potential in treating other diseases. Its applications span across various aspects of COVID-19 management, including prevention, diagnosis, treatment, vaccination, and research.

EMERGENT MATERIALS (2021)

Article Multidisciplinary Sciences

Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice

Alexander A. Cohen et al.

Summary: The study developed nanoparticles displaying the receptor binding domain (RBD) of SARS-CoV-2 and other animal coronaviruses, which induced cross-reactive antibody responses in mice. Immunization with mosaic RBD nanoparticles resulted in superior neutralization of heterologous viruses, providing a potential strategy for simultaneous protection against multiple coronaviruses.

SCIENCE (2021)

Review Nanoscience & Nanotechnology

Advancements in protein nanoparticle vaccine platforms to combat infectious disease

Nina Butkovich et al.

Summary: Protein nanoparticles are a promising vaccine platform for preventing infectious diseases, offering fewer safety concerns and strong immune responses in animal models. Continued research on these novel vaccine platforms is crucial for generating safer alternatives to current vaccines, advancing vaccines for diseases with lacking prophylactic therapies, and preparing for the rapid development of new vaccines against emerging infectious diseases.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2021)

Article Immunology

Tocilizumab for Severe Worsening COVID-19 Pneumonia: a Propensity Score Analysis

Mathilde Roumier et al.

Summary: Treatment with tocilizumab in patients with severe COVID-19 pneumonia showed reduced need for overall ventilatory support, an increased rate of oxygen withdrawal, and higher discharge rate at D28. However, there was no significant improvement in overall survival. Higher rates of neutropenia were observed in the tocilizumab group, while rates of infections, including ventilator-acquired pneumonia, were higher in the control group. These findings could guide future trials aimed at managing COVID-19-induced inflammation, particularly before ICU admission.

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Article Medicine, General & Internal

Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies

Azza Sarfraz et al.

Summary: This study investigated the therapeutic benefits of Tocilizumab for severely infected COVID-19 patients through systematic searches and meta-analysis, demonstrating a lower mortality rate in the treatment group. Additionally, it provided a descriptive analysis of ongoing clinical trials for COVID-19 with Tocilizumab.

TURKISH JOURNAL OF MEDICAL SCIENCES (2021)

Article Infectious Diseases

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR

Victor M. Corman et al.

EUROSURVEILLANCE (2020)

Article Infectious Diseases

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih-Cheng Lai et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

Article Multidisciplinary Sciences

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Peng Zhou et al.

NATURE (2020)

Review Chemistry, Multidisciplinary

Diagnosing COVID-19: The Disease and Tools for Detection

Buddhisha Udugama et al.

ACS NANO (2020)

Editorial Material Biochemistry & Molecular Biology

COVID-19 infection: the perspectives on immune responses

Yufang Shi et al.

CELL DEATH AND DIFFERENTIATION (2020)

Review Medical Laboratory Technology

Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence

Mary Kathryn Bohn et al.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)

Review Biochemistry & Molecular Biology

Cytokine storm intervention in the early stages of COVID-19 pneumonia

Xinjuan Sun et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Review Biochemistry & Molecular Biology

COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons

Shivraj Hariram Nile et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2020)

Article Infectious Diseases

A mathematical model for simulating the phase-based transmissibility of a novel coronavirus

Tian-Mu Chen et al.

INFECTIOUS DISEASES OF POVERTY (2020)

Article Infectious Diseases

Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

Philippe Gautret et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Medicine, General & Internal

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma

Chenguang Shen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Effective treatment of severe COVID-19 patients with tocilizumab

Xiaoling Xu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Editorial Material Cardiac & Cardiovascular Systems

COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal

Hasan K. Siddiqi et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)

Editorial Material Multidisciplinary Sciences

The search for a COVID-19 animal model

Seema S. Lakdawala et al.

SCIENCE (2020)

Editorial Material Pharmacology & Pharmacy

In Vitro and Animal Models for SARS-CoV-2 research

Kazuo Takayama

TRENDS IN PHARMACOLOGICAL SCIENCES (2020)

Editorial Material Medicine, General & Internal

Covid-19: risk factors for severe disease and death

Rachel E. Jordan et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Biotechnology & Applied Microbiology

Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?

Martina Bianchi et al.

BIOMED RESEARCH INTERNATIONAL (2020)

Article Biology

SARS-CoV-2 (COVID-19) by the numbers

Yinon M. Bar-On et al.

ELIFE (2020)

Article Critical Care Medicine

Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy

Peter M. George et al.

LANCET RESPIRATORY MEDICINE (2020)

Article Chemistry, Multidisciplinary

Assay Techniques and Test Development for COVID-19 Diagnosis

Linda J. Carter et al.

ACS CENTRAL SCIENCE (2020)

Article Biochemistry & Molecular Biology

A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells

Markus Hoffmann et al.

MOLECULAR CELL (2020)

Review Medicine, General & Internal

The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control

Yosra A. Helmy et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Article Multidisciplinary Sciences

Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody

Dora Pinto et al.

NATURE (2020)

Article Biotechnology & Applied Microbiology

CRISPR-Cas12-based detection of SARS-CoV-2

James P. Broughton et al.

NATURE BIOTECHNOLOGY (2020)

Article Biotechnology & Applied Microbiology

RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2

Wei E. Huang et al.

MICROBIAL BIOTECHNOLOGY (2020)

Review Pharmacology & Pharmacy

Molecular immune pathogenesis and diagnosis of COVID-19

Xiaowei Li et al.

JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)

Review Chemistry, Multidisciplinary

Nanotechnology for COVID-19: Therapeutics and Vaccine Research

Gaurav Chauhan et al.

ACS NANO (2020)

Article Chemistry, Multidisciplinary

Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic

Carsten Weiss et al.

ACS NANO (2020)

Review Chemistry, Multidisciplinary

Current Status of COVID-19 (Pre)Clinical Vaccine Development

Tingting Ye et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Article Infectious Diseases

Evolution of viral quasispecies during SARS-CoV-2 infection

Aude Jary et al.

CLINICAL MICROBIOLOGY AND INFECTION (2020)

Review Infectious Diseases

Can nanotechnology help in the fight against COVID-19?

Gabriela Palestino et al.

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2020)

Article Biochemistry & Molecular Biology

Genetic gateways to COVID-19 infection: Implications for risk, severity, and outcomes

Monojit Debnath et al.

FASEB JOURNAL (2020)

Article Microbiology

Geographic and Genomic Distribution of SARS-CoV-2 Mutations

Daniele Mercatelli et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Multidisciplinary Sciences

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

Muhammad Adnan Shereen et al.

JOURNAL OF ADVANCED RESEARCH (2020)

Article Virology

Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG

Alexander Krüttgen et al.

JOURNAL OF CLINICAL VIROLOGY (2020)

Article Infectious Diseases

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics

Eskild Petersen et al.

LANCET INFECTIOUS DISEASES (2020)

Article Infectious Diseases

C-reactive protein levels in the early stage of COVID-19

L. Wang

MEDECINE ET MALADIES INFECTIEUSES (2020)

Article Clinical Neurology

COVID-19-associated Guillain-Barresyndrome: The early pandemic experience

James B. Caress et al.

MUSCLE & NERVE (2020)

Review Biotechnology & Applied Microbiology

Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19

Noura H. Abd Ellah et al.

NANOMEDICINE (2020)

Review Immunology

Vaccines for COVID-19

J. S. Tregoning et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)

Review Pediatrics

Vaccines for COVID-19: The current state of play

Archana Koirala et al.

PAEDIATRIC RESPIRATORY REVIEWS (2020)

Article Pharmacology & Pharmacy

A molecular docking study repurposes FDA approved iron oxide nanoparticles to treat and control COVID-19 infection

Yasmin Abo-zeid et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)

Article Multidisciplinary Sciences

Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail

Johanna Hansen et al.

SCIENCE (2020)

Article Multidisciplinary Sciences

Broad neutralization of SARS-related viruses by human monoclonal antibodies

Anna Z. Wec et al.

SCIENCE (2020)

Article Cell Biology

A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples

Viet Loan Dao Thi et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Multidisciplinary Sciences

Bacterial polyphosphates interfere with the innate host defense to infection

Julian Roewe et al.

NATURE COMMUNICATIONS (2020)

Review Infectious Diseases

Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status

Tarek Mohamed Abd El-Aziz et al.

INFECTION GENETICS AND EVOLUTION (2020)

Article Medicine, General & Internal

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis

Jonathan A. C. Sterne et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Letter Medicine, Research & Experimental

Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanoconjugate

Rituparna Acharya

MEDICAL HYPOTHESES (2020)

Review Immunology

Animal and translational models of SARS-CoV-2 infection and COVID-19

M. D. Johansen et al.

MUCOSAL IMMUNOLOGY (2020)

Review Multidisciplinary Sciences

Animal models for COVID-19

Cesar Munoz-Fontela et al.

NATURE (2020)

Editorial Material Biotechnology & Applied Microbiology

Evolution of the COVID-19 vaccine development landscape

Tung Thanh Le et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Article Medicine, General & Internal

Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19

Peter Horby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, General & Internal

Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

News Item Medicine, General & Internal

Covid-19: Eli Lilly pauses antibody trial for safety reasons

Owen Dyer

BMJ-BRITISH MEDICAL JOURNAL (2020)

Article Engineering, Biomedical

Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

Maturada Patchsung et al.

NATURE BIOMEDICAL ENGINEERING (2020)

Editorial Material Medicine, General & Internal

FDA Approval of Remdesivir - A Step in the Right Direction

Daniel Rubin et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Pharmacology & Pharmacy

Chloroquine, hydroxychloroquine, and COVID-19: Systematic review and narrative synthesis of efficacy and safety

Michael Takla et al.

SAUDI PHARMACEUTICAL JOURNAL (2020)

Article Medicine, General & Internal

Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study

Roberto Pastor-Barriuso et al.

BMJ-BRITISH MEDICAL JOURNAL (2020)

Letter Rheumatology

Tocilizumab for severe COVID-19 pneumonia Reply

Giovanni Guaraldi et al.

LANCET RHEUMATOLOGY (2020)

Article Multidisciplinary Sciences

Explaining among-country variation in COVID-19 case fatality rate

Gabriele Sorci et al.

SCIENTIFIC REPORTS (2020)

Article Multidisciplinary Sciences

Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O'Driscoll et al.

NATURE (2020)

Article Infectious Diseases

Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission

Sayantan Laha et al.

INFECTION GENETICS AND EVOLUTION (2020)

Article Immunology

Cross-reactive memory T cells and herd immunity to SARS-CoV-2

Marc Lipsitch et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Article Nanoscience & Nanotechnology

Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19

Lixin Liu et al.

ACS APPLIED BIO MATERIALS (2020)

Review Medicine, Research & Experimental

The role of passive immunization in the age of SARS-CoV-2: an update

Johannes C. Fischer et al.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2020)

Review Medicine, General & Internal

COVID-19 Diagnostic and Management Protocol for Pediatric Patients

Ana Paula de Carvalho Panzeri Carlotti et al.

CLINICS (2020)

Review Biochemistry & Molecular Biology

Zoonotic origins of human coronaviruses

Zi-Wei Ye et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2020)

Article Infectious Diseases

Iron oxide nanoparticles based antiviral activity of H1N1 influenza A virus

Rishikesh Kumar et al.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)

Review Biochemistry & Molecular Biology

Mechanistic Insights into the Antimicrobial Actions of Metallic Nanoparticles and Their Implications for Multidrug Resistance

Sibhghatulla Shaikh et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Virology

Coronavirus envelope protein: current knowledge

Dewald Schoeman et al.

VIROLOGY JOURNAL (2019)

Article Multidisciplinary Sciences

Spy&Go purification of SpyTag-proteins using pseudo-SpyCatcher to access an oligomerization toolbox

Irsyad N. A. Khairil Anuar et al.

NATURE COMMUNICATIONS (2019)

Review Biotechnology & Applied Microbiology

The indications and safety of polyvalent immunoglobulin for post-exposure prophylaxis of hepatitis A, rubella and measles

Megan K. Young

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)

Article Biochemistry & Molecular Biology

The pituitary gland prevents shock-associated death by controlling multiple inflammatory mediators

Arjun Sharma et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)

Review Immunology

Nanoparticle-Based Vaccines Against Respiratory Viruses

Soultan Al-Halifa et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Medicine, General & Internal

Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice

Mohamed Anwar Hammad et al.

JOURNAL OF RESEARCH IN MEDICAL SCIENCES (2019)

Article Toxicology

Nanoparticles in Daily Life: Applications, Toxicity and Regulations

Ritu Gupta et al.

JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY (2018)

Article Multidisciplinary Sciences

GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses

Michael K. Lo et al.

SCIENTIFIC REPORTS (2017)

Review Chemistry, Multidisciplinary

Design of virus-based nanomaterials for medicine, biotechnology, and energy

Amy M. Wen et al.

CHEMICAL SOCIETY REVIEWS (2016)

Review Oncology

From SARS to MERS: evidence and speculation

Hainv Gao et al.

FRONTIERS OF MEDICINE (2016)

Article Public, Environmental & Occupational Health

Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome

Davide Corti et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)

Article Pharmacology & Pharmacy

Safety of Nanoparticles in Medicine

Joy Wolfram et al.

CURRENT DRUG TARGETS (2015)

Article Respiratory System

Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells

Aline Schogler et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Review Chemistry, Multidisciplinary

The Challenge To Relate the Physicochemical Properties of Colloidal Nanoparticles to Their Cytotoxicity

Pilar Rivera-Gil et al.

ACCOUNTS OF CHEMICAL RESEARCH (2013)

Article Chemistry, Multidisciplinary

Discovery of HepatitisC Virus NS3 Helicase Inhibitors by a Multiplexed, High-Throughput Helicase Activity Assay Based on Graphene Oxide

Hongje Jang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)

Review Nanoscience & Nanotechnology

Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers

Wahajuddin et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2012)

Article Infectious Diseases

Characterisation of copper oxide nanoparticles for antimicrobial applications

Guogang Ren et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)

Article

Toxicity and Environmental Risks of Nanomaterials: Challenges and Future Needs

PARESH CHANDRA RAY et al.

JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2009)

Article Multidisciplinary Sciences

Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings

Christophe Fraser et al.

SCIENCE (2009)

Review Nanoscience & Nanotechnology

Drug delivery and nanoparticles: Applications and hazards

Wim H. De Jong et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2008)

Review Microbiology

Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection

Vincent C. C. Cheng et al.

CLINICAL MICROBIOLOGY REVIEWS (2007)

Article Chemistry, Multidisciplinary

Bio-distribution, toxicity and pathology of cowpea mosaic virus nanoparticles in vivo

Pratik Singh et al.

JOURNAL OF CONTROLLED RELEASE (2007)

Article Spectroscopy

Biosynthesis of gold nanoparticles using Pseudomonas aeruginosa

M. I. Husseiny et al.

SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2007)

Article Biotechnology & Applied Microbiology

Bioreductive deposition of platinum nanoparticles on the bacterium Shewanella algae

Yasuhiro Konishi et al.

JOURNAL OF BIOTECHNOLOGY (2007)

Review Pharmacology & Pharmacy

How corticosteroids control inflammation: Quintiles prize lecture 2005

Peter J. Barnes

BRITISH JOURNAL OF PHARMACOLOGY (2006)

Article Microbiology

Coronavirus HKU1 and other coronavirus infections in Hong Kong

Susanna K. P. Lau et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2006)

Article Biochemistry & Molecular Biology

Human immunodeficiency virus type 1 Gag assembly through assembly intermediates

Y Morikawa et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)